Vivo Bio Tech share news, announcements and annual reports
NSE: VIVOBIOTBSE: 511509Pharmaceuticals & BiotechnologySmall Cap
Vivo Bio Tech Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 1994
Last close ₹13.87down ₹0.31 (2.19%)BSE ₹13.85
Share price at the NSE close on 28 Oct 2026. Previous close ₹14.18.
28 Oct: open ₹14.18, high ₹14.39, low ₹13.38
52-week range of BSE trades to 28 Oct 2026
₹12.20Low, 26 Oct 2026₹35.76High, 13 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹31 Cr3,302nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.33
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −3.3%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.60 crore of one-off items, the largest of them in the quarter to Mar 2026.
- −2.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 5.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.72
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 15,01869.0% delivered
Vivo Bio Tech share news and announcements
594 announcements, routine notices left out, newest first. Page 12 of 12.
Jul 2014
22 Jul · Shareholding Pattern For June 30, 2014
11 Jul · Results
May 2014
29 May · Board meeting
Board of Directors of the Company at its meeting held on May 28, 2014, inter alia, has transacted the following : 1. Considered and approved ....
Apr 2014
21 Apr · Shareholding Pattern For March 31, 2014
Mar 2014
31 Mar · Management
Company have appointed Mr. Varun Kumar Challapalli as Company secretary of the Company with effect from March 29, 2014.
Feb 2014
Dec 2013
17 Dec · Management
Dr. V. Narasaiah resigned to the office of Director and other committee positions he is holding in the Company with effect from December 17, 2013 ....
Nov 2013
Sep 2013
Aug 2013
29 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 29, 2013, has transacted the following : 1. Approved the Notice and Directors ....22 Aug · Board Meeting on August 29, 2013
Meeting of the Board of Directors of the Company will be held on August 29, 2013, inter alia, to consider the following items: 1. To Approve ....
Jul 2013
30 Jul · Board meeting
Board of Directors of the Company at its meeting held on July 30, 2013, has transacted the following business: 1. Approved the Resignation ....
May 2013
Feb 2013
Nov 2012
Oct 2012
Aug 2012
31 Aug · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 20, 2012 to September 29, 2012 (both days inclusive) ....
May 2012
14 May · Board meeting
Board of Directors of the Company at its meeting held on May 12, 2012, inter alia, has approved the re-appointment of Dr. A. Sankaranarayanan ....
Feb 2012
10 Feb · Limited Review for Dec 31, 2011
10 Feb · Results
Nov 2011
14 Nov · Results
Sep 2011
29 Sep · Meeting
Members at the Annual General Meeting (AGM) of the Company held on September 29, 2011, inter alia, have passed the following: 1. Approved ....3 Sep · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 23, 2011 to September 29, 2011 (both days inclusive) ....
Aug 2011
8 Aug · Results
May 2011
13 May · Results
Mar 2011
Feb 2011
11 Feb · Results
Dec 2010
24 Dec · Board meeting
Board of Directors of the Company at its meeting held on December 24, 2010, inter alia, has transacted the following business: 1. Approved ....20 Dec · Board Meeting on Dec 24, 2010
Meeting of the Board of Directors of the Company will be held on December 24, 2010 to consider the following items. - To discuss on the ....
Nov 2010
11 Nov · Results
Sep 2010
29 Sep · Meeting
Members at the 23rd Annual General Meeting (AGM) of the Company held on September 29, 2010, inter alia, have passed the following resolutions: ....2 Sep · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 26, 2010 to September 29, 2010 (both days inclusive) ....1 Sep · Board meeting
Board of Directors of the Company at its meeting held on August 31, 2010, inter alia, has transacted the following business: 1. The 23rd ....
Aug 2010
20 Aug · Disclosure
Vivo Bio Tech Ltd has submitted the disclosure under Regulation 7(3) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE2 Aug · Results
Jul 2010
26 Jul · Disclosure
Vivo Bio Tech Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE:
Apr 2010
30 Apr · Results